Cargando…

Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS

Epitope characterization is critical for elucidating the mechanism of action of drug candidates. However, traditional high-resolution epitope mapping techniques are not well suited for screening numerous drug candidates recognizing a similar target. Here, we use Hydrogen-Deuterium Exchange Mass Spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Puchades, Cristina, Kűkrer, Başak, Diefenbach, Otto, Sneekes-Vriese, Eveline, Juraszek, Jarek, Koudstaal, Wouter, Apetri, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427009/
https://www.ncbi.nlm.nih.gov/pubmed/30894620
http://dx.doi.org/10.1038/s41598-019-41179-0
_version_ 1783405118273617920
author Puchades, Cristina
Kűkrer, Başak
Diefenbach, Otto
Sneekes-Vriese, Eveline
Juraszek, Jarek
Koudstaal, Wouter
Apetri, Adrian
author_facet Puchades, Cristina
Kűkrer, Başak
Diefenbach, Otto
Sneekes-Vriese, Eveline
Juraszek, Jarek
Koudstaal, Wouter
Apetri, Adrian
author_sort Puchades, Cristina
collection PubMed
description Epitope characterization is critical for elucidating the mechanism of action of drug candidates. However, traditional high-resolution epitope mapping techniques are not well suited for screening numerous drug candidates recognizing a similar target. Here, we use Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) to explore the conformational impact of diverse drug molecules binding on Hemagglutinin (HA), the major surface antigen of influenza viruses. We optimized a semi-automated HDX-MS workflow to systematically probe distantly related HA subtypes in complex with 4 different drug candidates, ranging from a monoclonal antibody to a small synthetic peptide. This fast, cost-effective HDX-MS epitope mapping approach accurately determined the main antigenic site in all cases. Moreover, our studies reveal distinct changes in the local conformational dynamics of HA associated to the molecular mechanism of neutralization, establishing a marker for broad anti-HA activity. Taken together, these findings highlight the potential for HDX-MS epitope mapping-based screening to identify promising candidates against HA at early stages of drug discovery.
format Online
Article
Text
id pubmed-6427009
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-64270092019-03-28 Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS Puchades, Cristina Kűkrer, Başak Diefenbach, Otto Sneekes-Vriese, Eveline Juraszek, Jarek Koudstaal, Wouter Apetri, Adrian Sci Rep Article Epitope characterization is critical for elucidating the mechanism of action of drug candidates. However, traditional high-resolution epitope mapping techniques are not well suited for screening numerous drug candidates recognizing a similar target. Here, we use Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) to explore the conformational impact of diverse drug molecules binding on Hemagglutinin (HA), the major surface antigen of influenza viruses. We optimized a semi-automated HDX-MS workflow to systematically probe distantly related HA subtypes in complex with 4 different drug candidates, ranging from a monoclonal antibody to a small synthetic peptide. This fast, cost-effective HDX-MS epitope mapping approach accurately determined the main antigenic site in all cases. Moreover, our studies reveal distinct changes in the local conformational dynamics of HA associated to the molecular mechanism of neutralization, establishing a marker for broad anti-HA activity. Taken together, these findings highlight the potential for HDX-MS epitope mapping-based screening to identify promising candidates against HA at early stages of drug discovery. Nature Publishing Group UK 2019-03-18 /pmc/articles/PMC6427009/ /pubmed/30894620 http://dx.doi.org/10.1038/s41598-019-41179-0 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Puchades, Cristina
Kűkrer, Başak
Diefenbach, Otto
Sneekes-Vriese, Eveline
Juraszek, Jarek
Koudstaal, Wouter
Apetri, Adrian
Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS
title Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS
title_full Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS
title_fullStr Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS
title_full_unstemmed Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS
title_short Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS
title_sort epitope mapping of diverse influenza hemagglutinin drug candidates using hdx-ms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427009/
https://www.ncbi.nlm.nih.gov/pubmed/30894620
http://dx.doi.org/10.1038/s41598-019-41179-0
work_keys_str_mv AT puchadescristina epitopemappingofdiverseinfluenzahemagglutinindrugcandidatesusinghdxms
AT kukrerbasak epitopemappingofdiverseinfluenzahemagglutinindrugcandidatesusinghdxms
AT diefenbachotto epitopemappingofdiverseinfluenzahemagglutinindrugcandidatesusinghdxms
AT sneekesvrieseeveline epitopemappingofdiverseinfluenzahemagglutinindrugcandidatesusinghdxms
AT juraszekjarek epitopemappingofdiverseinfluenzahemagglutinindrugcandidatesusinghdxms
AT koudstaalwouter epitopemappingofdiverseinfluenzahemagglutinindrugcandidatesusinghdxms
AT apetriadrian epitopemappingofdiverseinfluenzahemagglutinindrugcandidatesusinghdxms